NCT06689241View on ClinicalTrials.gov

Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery

NARecruitingINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

May 1, 2026

Conditions

Morbid ObesityBariatric Surgery Candidate

Interventions

DRUG

Enoxaparin

40mg

DRUG

rivaroxaban

10mg

Trial Locations (1)

Unknown

RECRUITING

Alexandria University, Alexandria

All Listed Sponsors

lead

Alexandria University

OTHER